Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AMITRIPTYLINE Cause Neuropathy peripheral? 151 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 151 reports of Neuropathy peripheral have been filed in association with AMITRIPTYLINE (AMITRIPTYLINE HYDROCHLORIDE). This represents 0.7% of all adverse event reports for AMITRIPTYLINE.

151
Reports of Neuropathy peripheral with AMITRIPTYLINE
0.7%
of all AMITRIPTYLINE reports
2
Deaths
44
Hospitalizations

How Dangerous Is Neuropathy peripheral From AMITRIPTYLINE?

Of the 151 reports, 2 (1.3%) resulted in death, 44 (29.1%) required hospitalization, and 8 (5.3%) were considered life-threatening.

Is Neuropathy peripheral Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AMITRIPTYLINE. However, 151 reports have been filed with the FAERS database.

What Other Side Effects Does AMITRIPTYLINE Cause?

Toxicity to various agents (3,001) Drug ineffective (2,344) Completed suicide (1,678) Off label use (1,588) Pain (1,300) Fall (1,216) Hypotension (1,205) Drug abuse (1,116) Dizziness (1,041) Constipation (1,035)

What Other Drugs Cause Neuropathy peripheral?

LENALIDOMIDE (10,215) BORTEZOMIB (4,067) OXALIPLATIN (3,662) DEXAMETHASONE (3,543) PACLITAXEL (3,508) LEVOFLOXACIN (2,619) CIPROFLOXACIN (2,607) FLUOROURACIL (2,605) CYCLOPHOSPHAMIDE (2,565) POMALIDOMIDE (2,382)

Which AMITRIPTYLINE Alternatives Have Lower Neuropathy peripheral Risk?

AMITRIPTYLINE vs AMITRIPTYLINE\PERPHENAZINE AMITRIPTYLINE vs AMIVANTAMAB AMITRIPTYLINE vs AMIVANTAMAB-VMJW AMITRIPTYLINE vs AMLODIPINE AMITRIPTYLINE vs AMLODIPINE BESILATE

Related Pages

AMITRIPTYLINE Full Profile All Neuropathy peripheral Reports All Drugs Causing Neuropathy peripheral AMITRIPTYLINE Demographics